BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17266311)

  • 1. On the substrate specificity of dehydration by lacticin 481 synthetase.
    Zhang X; van der Donk WA
    J Am Chem Soc; 2007 Feb; 129(8):2212-3. PubMed ID: 17266311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity.
    Xie L; Miller LM; Chatterjee C; Averin O; Kelleher NL; van der Donk WA
    Science; 2004 Jan; 303(5658):679-81. PubMed ID: 14752162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dehydratase activity of lacticin 481 synthetase is highly processive.
    Miller LM; Chatterjee C; van der Donk WA; Kelleher NL
    J Am Chem Soc; 2006 Feb; 128(5):1420-1. PubMed ID: 16448091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis.
    You YO; van der Donk WA
    Biochemistry; 2007 May; 46(20):5991-6000. PubMed ID: 17455908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation by LctT is required for biosynthesis of full-length lantibiotic lacticin 481.
    Uguen P; Hindré T; Didelot S; Marty C; Haras D; Le Pennec JP; Vallée-Réhel K; Dufour A
    Appl Environ Microbiol; 2005 Jan; 71(1):562-5. PubMed ID: 15640237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
    Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
    J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leader peptide is not required for post-translational modification by lacticin 481 synthetase.
    Levengood MR; Patton GC; van der Donk WA
    J Am Chem Soc; 2007 Aug; 129(34):10314-5. PubMed ID: 17676843
    [No Abstract]   [Full Text] [Related]  

  • 9. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
    Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
    Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids.
    Levengood MR; Kerwood CC; Chatterjee C; van der Donk WA
    Chembiochem; 2009 Mar; 10(5):911-9. PubMed ID: 19222036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
    Suda S; Westerbeek A; O'Connor PM; Ross RP; Hill C; Cotter PD
    Chem Biol; 2010 Oct; 17(10):1151-60. PubMed ID: 21035738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids.
    Levengood MR; Knerr PJ; Oman TJ; van der Donk WA
    J Am Chem Soc; 2009 Sep; 131(34):12024-5. PubMed ID: 19655738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Michael-type cyclizations in lantibiotic biosynthesis are reversible.
    Yang X; van der Donk WA
    ACS Chem Biol; 2015 May; 10(5):1234-8. PubMed ID: 25723375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases.
    Zhang X; van der Donk WA
    Methods Enzymol; 2009; 462():117-34. PubMed ID: 19632472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriocin detection from whole bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Hindré T; Didelot S; Le Pennec JP; Haras D; Dufour A; Vallée-Réhel K
    Appl Environ Microbiol; 2003 Feb; 69(2):1051-8. PubMed ID: 12571028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies of the two-component lantibiotic haloduracin.
    Cooper LE; McClerren AL; Chary A; van der Donk WA
    Chem Biol; 2008 Oct; 15(10):1035-45. PubMed ID: 18940665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microcin E492 is an unmodified peptide related in structure to colicin V.
    Pons AM; Zorn N; Vignon D; Delalande F; Van Dorsselaer A; Cottenceau G
    Antimicrob Agents Chemother; 2002 Jan; 46(1):229-30. PubMed ID: 11751140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli.
    Shi Y; Bueno A; van der Donk WA
    Chem Commun (Camb); 2012 Nov; 48(89):10966-8. PubMed ID: 23034674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14.
    Iwatani S; Zendo T; Yoneyama F; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2007 Aug; 71(8):1984-92. PubMed ID: 17690480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-solution digestion of proteins for mass spectrometry.
    Medzihradszky KF
    Methods Enzymol; 2005; 405():50-65. PubMed ID: 16413310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.